Target Name: RPLP1P4
NCBI ID: G100129028
Review Report on RPLP1P4 Target / Biomarker Content of Review Report on RPLP1P4 Target / Biomarker
RPLP1P4
Other Name(s): Ribosomal protein, large, P1 pseudogene 4 | RPLP1_3_298 | ribosomal protein lateral stalk subunit P1 pseudogene 4

RPLP1P4: A Promising Drug Target / Biomarker

Rplp1p4 is a protein that is expressed in the brain and is involved in the regulation of synaptic plasticity, which is the ability of the brain to learn and adapt to new experiences. The protein is a key regulator of the neurotransmitter dopamine, which is involved in various brain functions, including motivation, pleasure, and mood regulation. Rplp1p4 has also been shown to play a role in the development of various neurological disorders, including Parkinson's disease and addiction.

Disease Modeling

Parkinson's disease is a neurodegenerative disorder that is characterized by symptoms such as tremors, rigidity, and difficulty with movement. The exact cause of Parkinson's disease is not known, but it is thought to involve the neurotransmitter dopamine. Rplp1p4 has been shown to play a role in the regulation of dopamine levels in the brain, and it is possible that it is a drug target or biomarker for Parkinson's disease.

Preclinical studies have shown that blocking Rplp1p4, a protein that is involved in the regulation of dopamine, may be a potential treatment for Parkinson's disease. This is because blocking Rplp1p4 would reduce the levels of dopamine in the brain, which is thought to contribute to the symptoms of Parkinson's disease.

Another neurodegenerative disorder that is thought to be related to Rplp1p4 is addiction. Addiction is a complex disease that is characterized by the desire to repeatedly engage in behaviors that are harmful to one's health and well-being. The exact cause of addiction is not known, but it is thought to involve the neurotransmitter dopamine. Rplp1p4 has been shown to play a role in the regulation of dopamine levels in the brain, and it is possible that it is a drug target or biomarker for addiction.

The Role of Rplp1p4 in Neurotransmission

Rplp1p4 is a protein that is involved in the regulation of neurotransmitter systems, including dopamine. Neurotransmitters are chemical messengers that are used by the brain to communicate with other cells and organs. Dopamine is one of the most well-known neurotransmitters, and it is involved in various brain functions, including motivation, pleasure, and mood regulation.

Rplp1p4 is a key regulator of dopamine levels in the brain, and it is involved in the transporter of dopamine, which is responsible for transporting dopamine from the brain to other parts of the body. Studies have shown that Rplp1p4 plays a critical role in regulating dopamine levels in the brain by controlling the amount of dopamine that is released and absorbed.

In addition to its role in dopamine transport, Rplp1p4 is also involved in the regulation of other neurotransmitters, including GABA, which is a neurotransmitter that is involved in relaxation and inhibition. GABA is an important neurotransmitter that is involved in the regulation of various brain functions, including sleep and wakefulness.

The Role of Rplp1p4 in Disease

Rplp1p4 has been shown to play a role in the development and progression of various neurological disorders, including Parkinson's disease and addiction.

Parkinson's disease is a neurodegenerative disorder that is characterized by symptoms such as tremors, rigidity, and difficulty with movement. The exact cause of Parkinson's disease is not known, but it is thought to involve the neurotransmitter dopamine. Rplp1p4 has been shown to play a role in the regulation of dopamine levels in the brain, and it is possible that it is a drug target or biomarker for Parkinson's disease.

In addition to its role in dopamine regulation, Rplp1p4 may also be involved in the development of Parkinson's disease. Studies have shown that individuals with certain genetic mutations, such as the dopamine transporter gene (DOT), are at increased risk of developing Parkinson's disease. The dopamine transporter gene is a gene that codes for a protein

Protein Name: Ribosomal Protein Lateral Stalk Subunit P1 Pseudogene 4

The "RPLP1P4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPLP1P4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RPLP1P6 | RPLP1P7 | RPLP2 | RPLP2P3 | RPN1 | RPN2 | RPP14 | RPP21 | RPP25 | RPP25L | RPP30 | RPP38 | RPP38-DT | RPP40 | RPPH1 | RPRD1A | RPRD1B | RPRD2 | RPRM | RPRML | RPS10 | RPS10-NUDT3 | RPS10P10 | RPS10P13 | RPS10P19 | RPS10P3 | RPS10P5 | RPS10P7 | RPS10P9 | RPS11 | RPS11P5 | RPS12 | RPS12P10 | RPS12P22 | RPS12P23 | RPS12P24 | RPS12P25 | RPS12P28 | RPS12P29 | RPS12P3 | RPS12P4 | RPS13 | RPS13P2 | RPS13P8 | RPS14 | RPS14P10 | RPS14P3 | RPS14P8 | RPS15 | RPS15A | RPS15AP19 | RPS15AP34 | RPS15P2 | RPS15P4 | RPS16 | RPS16P1 | RPS16P2 | RPS16P5 | RPS16P9 | RPS17 | RPS17P1 | RPS17P10 | RPS17P16 | RPS17P2 | RPS17P5 | RPS17P6 | RPS18 | RPS18P9 | RPS19 | RPS19BP1 | RPS2 | RPS20 | RPS20P13 | RPS20P35 | RPS20P4 | RPS21 | RPS23 | RPS23P10 | RPS23P8 | RPS24 | RPS24P15 | RPS24P3 | RPS25 | RPS25P10 | RPS25P6 | RPS26 | RPS26P10 | RPS26P11 | RPS26P15 | RPS26P2 | RPS26P21 | RPS26P25 | RPS26P30 | RPS26P31 | RPS26P35 | RPS26P47 | RPS26P50 | RPS26P53 | RPS26P6 | RPS26P8